Characterization of HBeAg-negative chronic hepatitis B in western Brazilian Amazonia

Brazilian Journal of Infectious Diseases

Volumn 12, Issue 1, 2008, Pages 27-37

  da Silva Victoria, Flamir ^a,c   de Oliveira, Cintia Mara Costa ^a   Victoria, Marilu Barbieri ^a   Victoria, Cristian Barbieri ^b   Ferreira, Luis Carlos Lima ^a  

^a FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^b UNIVERSIDADE NILTON LINS   (Brazil)

^c NONE   (Brazil)

Author keywords

HBeAg negative chronic hepatitis B; Mutations; Western Brazilian Amazonia

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B(E) ANTIGEN; PROTHROMBIN; SERUM ALBUMIN; VIRUS DNA;

ADULT; AGE DISTRIBUTION; ANAMNESIS; ARTICLE; ASTHENIA; BRAZIL; CONTROLLED STUDY; DISEASE COURSE; DYSPEPSIA; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; INDIGENOUS PEOPLE; LIBIDO DISORDER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROMOTER REGION; SEX RATIO; SPLENOMEGALY; THROMBOCYTE COUNT; TIME; VIRUS CARRIER; VIRUS GENE; VIRUS LOAD;

EID: 48249145429     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1413-86702008000100008     Document Type: Article

References (46)

1. Ferreira M.S. Diagnóstico e tratamento da hepatite B. Revista da Sociedade Brasileira de Medicina Tropical 2000;34:389-400.
2. Silveira T.R., Da Fonseca J.C. Hepatitis B seroprevalence in Latin América. Rev Panam Salud Publica 1999;6:378-83.
3. Tanaka J. Hepatitis B epidemiology in Latin America. Vaccine 2000; 18suppl 1:17-9.
4. Lee W.M. Hepatitis B virus infection. N Engl J Med 1997; 337:1733-45.
5. Hadziyannis S.J. Hepatitis B and antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepatitis Reviews 1995;1:7-36.
6. Rizzeto M. Volpes, R. Response of pre-core mutant chronic hepatitis B infection to lamivudine. J Med Virol 2000;61:398-402.
7. Karasawa T., Aizawa Y., Zeniya M., et al. Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B and antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion. J Med Virol 1995;45:373-80.
8. Sanger F.R. Nicklens S. & Coulson A.R. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci 1997;74:5463-67.
9. Vieira S., Hossne W.S. Metodologia Científica para a Área da Saúde. 7 ed. Rio de Janeiro: Elsevier, 2003.
10. Hsu Y.S,, Chien R.N., Yeh C.T., et al. Long-term outcome after spontaneous HbeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-7.
11. Funk M.L., Rosemberg D.M., Lok A.S. World-wide epidemiology of HbeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Virol Hepat 2002;9(1):52-61.
12. Sharma S.K., Chwla N.S.Y. Hepatitis B vírus: inactive carriers. J Virol 2005;2:82-6.
13. Fattovich G., Alberti A., Tremolada F., et al. Natural history of liver disease associated with hepatitis B virus VHB infection. In: Vyas, G. N.; Dienstag, J. L.; Hoofnagle, J. H. Viral Hepatitis and Liver Disease. Orlando: Grune & Stratton, 1984.
14. Cohen J., Mandolesi J.F., Laszio M., et al. Triatoma infestans as a vector of hepatitis B virus. Acta Gastroenterol Latinoam 1981; 11(1):215-23.
15. Heptonstal J. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B and antigen. N Engl J Med 1997; 336:178-85.
16. Kiffer C.R.V., Viana G.B., Cheinquer H. Epidemiologia; In: Focaccia, R. Tratado de Hepatite Virais. São Paulo: Atheneu, 2003.
17. Da Silva L.C., Madruga C.L., Carrilho F.J., et al. Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection. J Gastroenterol 1996;31(5):696-701.
18. Hadziyannis S.J., Vassipoulos D. Hepatitis B and antigen-negative chronic hepatitis B. Hepatology 2001;34:617-24.
19. Zacharakis G.H., Koskinas J., Kotsiou S., et al. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project). J Med Virol 2005;77:173-9.
20. Adinolfi L.E., Giordano M.G., Andreana A., et al. Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. J Hematology 2001;113:590-5.
21. Sherlock S., Dooley J. Chronic hepatitis: general features, and autoimmune chronic disease. In:Sherlock S., Dooley J. Disease of The Liver and Biliary System. 11 ed. Oxford: Blackwell Science. 321-33, 2002.
22. Kosugi S., Imai Y., Kurata Y., et al. Platelet-associated IgM elevated in patients with chronic hepatitis C contains no antiplatelet autoantibodies. Liver 1997;17:230.
23. Dittrichi S., Mattos A.A., Cheinquer H., et al. Correlação entre a contagem de plaquetas no sangue e o gradiente de pressão venosa hepática em pacientes cirróticos. Arq Gastroenterol 2005;42:35-40.
24. Ordinas A., Escolar G., Cirera I., et al. Existence of platelet-adhesion defect in patients with cirrhosis independent of hematocrit: studies under flow conditions. Hepatology 1996;24:1137-42.
25. Younger H.M., Hadoke P.F., Dilon J.F., et al. Platelet function in cirrhosis and the role of humoral factors. Eur J Gastroenterol Hepatol 1997;9:989.
26. Pratt D.S., Kaplan M.M. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000;342:1266-71.
27. Oberti F., Valsesia E., Pilette C., et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113(5):1609-16.
28. De Ritis F., Coltorti M., Giusti G. Serum-transaminase activities in liver disease. Lancet 1972;1(7752):685-7.
29. Gonçalves Jr., F.L., Pereira J.S.F., Silva C., et al. Hepatitis B virus DNA in sera of blood donors and of patients infected with hepatitis C virus and human immunodeficiency virus. Clin Diagn Lab Immunol 2004;10:718-20.
30. Ryder S.D. Guidelines of the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003;52:1-8.
31. Lok A.S.F., Mcmahon B.J. Chronic hepatitis B. Hepatology 2007; 45(2):507-39.
32. Norder H., Coupouce A.M. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HbsAg subtypes. Intervirology 2004;47:289-309.
33. Kramvis A., Weitzmann W.K.B.A., Kew C.M. Analysis of the complete genome of subgroup A hepatits B virus isolates from South Africa. J Gen Virol 2002;83:835-9.
34. Naumann H., Schaefer S., Yoshida C.E, et al. Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. J Gen Virol 1993;74:1627-32.
35. Tonetto P.A., Gonçalves N.S.L., Souza D.L., et al. Distribuição dos genótipos do vírus da hepatite B (VHB) entre pacientes cronicamente infectados na região de Campinas-SP. GED - Gastroenterologia e Endoscopia Digestiva 2005;24:6.
36. Conde S.R.S.S., Moia L.J.P., Barbosa M.S.B., et al. Prevalência de genótipos e de mutantes pré-core A-1896 do vírus da hepatitie B e suas implicações na hepatite crônica, em uma população da Amazônia Oriental. Rev Soc Bras Med Trop 2004;I (supl):33-9.
37. Bertolini D.A., Moreira R.C., Soares M., et al. Genotyping of hepatitis B virus in indigenous populations from Amazon Region Brazil. Virus Rev Res 2000;5(2-suppl 1);101.
38. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat 2004;12:111-24.
39. Rodriguez-Frias F., Jardi R., Buti M., et al. Hepatitis B virus genotypes and G1896A precore mutation in 486 Spanish patients with acute and chronic HBV infection. J Viral Hepat 2006;13(5):343-50.
40. Sakai T., Shiraki K., Sugimoto K., et al. Hepatitis B genotypes in patients with acute hepatitis B virus infection. J Hepatol 2001; 35:829-30.
41. Shina S., Fujino H., Uta Y., et al. Relationship of HBsAg subtypes with HbeAg/anti-HBe status and chronic liver disease. Part I analysis of 1744 HbsAg carriers. Am J Gastroenterol 1991;86:866-71.
42. Kao J.H., Wu N.H. Hepatities B genotypes and the response to interferon therapy. J Hepatol 2000;33:998-1002.
43. Orito E., Ichida T., Sakugava H., et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001;34:590-4.
44. Scaglioni P.P., Melegari M., Wands J.R. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 1997;233:374-81.
45. Gonçalves N.S.L.; Gonçalves Jr., L.F. Perfis sorológicos anômalos, genótipos e mutantes do VHB. J Infect Dis 2006;10:23-8.
46. Chu C.J., Keeffe E.B., Han S.H., et al. Prevalence of HBV Precore/core promoter variants in the United States. Hepatology 2003;38;619-28.